At the end of the last fiscal year, the U.S. Patent and Trademark Office issued the University of Mississippi Medical Center two patents and a trademark. Combined with record numbers of intellectual property applications and disclosures, these inventions represent the diversity of approaches our faculty take to advancing science and health care.
The Bench
About one in ten people in the U.S. have some form of chronic kidney disease, which kills about 50,000 Americans yearly.
“Currently, there are no effective treatments to reverse the course of chronic kidney disease,” said Dr. Alejandro Chade, professor of physiology and biophysics.
Chade is the co-inventor of a patent that covers the use of an elastin-like polypeptide, or ELP, to deliver drugs to the kidney. This patents also covers the use of a protein that promotes blood vessel growth in order to slow the progression of kidney disease. Chade, who studies vascular diseases, worked with co-inventor Dr. Gene Bidwell, associate professor of neurology, to create the drug delivery system.
Read more >> https://www.umc.edu/news/News_Articles/2019/09/Patents-and-Trademarks.html
No comments:
Post a Comment